2003
Influence of race, clinical, and other socio-demographic features on trial participation
Corbie-Smith G, Viscoli CM, Kernan WN, Brass LM, Sarrel P, Horwitz RI. Influence of race, clinical, and other socio-demographic features on trial participation. Journal Of Clinical Epidemiology 2003, 56: 304-309. PMID: 12767406, DOI: 10.1016/s0895-4356(03)00046-5.Peer-Reviewed Original ResearchConceptsTrial participationPrevious estrogen useClinical trial participationHistory of hysterectomyEstrogen useClinical characteristicsStroke trialsWomen's EstrogenClinical trialsConsent ratesCognitive impairmentSocio-demographic featuresMultivariate modelInfluence of raceHysterectomyEstrogenWomen's decisionsTrialsEthnic groupsImpairmentVisitsWomen
1999
Postmenopausal Estrogen Replacement Therapy Is Associated with Adverse Breast Cancer Prognostic Indices
LeBlanc ES, Viscoli CM, Henrich JB. Postmenopausal Estrogen Replacement Therapy Is Associated with Adverse Breast Cancer Prognostic Indices. Journal Of Women's Health 1999, 8: 815-823. PMID: 10495262, DOI: 10.1089/152460999319138.Peer-Reviewed Original ResearchConceptsEstrogen replacement therapyPrognostic indexERT usersTumor characteristicsPrognostic groupsReplacement therapyOdds ratioUsers of ERTPostmenopausal estrogen replacement therapyNegative estrogen receptor statusBiopsy-proven breast cancerFavorable tumor characteristicsBreast cancer patientsEstrogen receptor statusLong-term outcomesPoor prognostic groupTime of mammographyEarly-stage tumorsAdverse prognostic indexSelf-administered questionnairePositive nodesPostmenopausal womenERT useReceptor statusCancer patients